Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 572 | Longs Won 238/560 42% | Profit Factor 1.04 |
| Profitability | Shorts Won 6/12 50% | Standard Deviation $1,601.94 |
| Average Win $583.98 | Best Trade (Aug 18) $15,128.77 | Sharpe Ratio -362.37 |
| Average Loss -$419.47 | Worst Trade (May 14) -$21,157.42 | Z-Score -5.85 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1d | Expectancy $8.57 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 9.15% | 18.79% | 28.63% | 38.6% | 48.67% | 58.82% | 69.04% | 79.31% | 89.63% |
| Consecutive Losing Trades | 372 | 335 | 298 | 260 | 223 | 186 | 149 | 112 | 74 | 37 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
SLDB Solid Biosciences Inc. | 5,765.13 | $53,731 | $53,731 | - | - | - | +2.418% |